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Abstract tRNA-guanine transglycosylases (TGTs) are the 
enzymes catalyzing the base exchange required for the synthesis 
of the modified bases derived from 7-deazaguanine in prokar-
yotic, archaebacterial, and eukaryotic tRNAs. Unlike the 
eukaryotic and archaebacterial enzymes, the prokaryotic TGTs 
have been clearly identified and highly characterized both 
biochemically and structurally. The recent occurrence in 
sequence databases of archaebacterial and eukaryotic proteins 
homologous to the prokaryotic TGTs reveals that all TGTs 
unexpectedly adopt a common fold. Observed sequence varia-
tions at the active site correlate well with their specificities for 
the various 7-deazaguanine derivatives and the total conservation 
of the catalytic residues strongly favors a common catalytic 
mechanism for all TGTs. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Many modified bases are found in RNA and especially in 
tRNA [1] where they play various biochemical and structural 
roles [2]. Among them are the 7-deazaguanine derivatives 
queuine and archaeosine (Fig. 1). Queuine is found at the 
wobble position of prokaryotic and eukaryotic tRNAs specific 
for Asn, Asp, His and Tyr, with the exception of yeast and 
archaebacteria [3-5]. Several studies have highlighted the role 
of queuine at the translational level [6-12], although the free 
base may also play a role in the eukaryotic metabolism [13]. 
Additionally, queuine-modified tRNA levels have been shown 
to vary during development, differentiation, aging and cancer 
[14,15]. On the other hand, archaeosine is found exclusively at 
position 15 in the D-loop of most archaebacterial tRNAs 
where it is believed to play a structural role [16]. 
The synthesis of these derivatives is unique since, unlike the 
other modified bases, it starts outside the tRNA and requires 
a base exchange reaction catalyzed by enzymes known as 
tRNA-guanine transglycosylases (TGTs). In prokaryotes, 
queuine is synthesized de novo in a complex biosynthetic 
pathway [17]. The prokaryotic TGT is a 43 kDa zinc-contain-
ing enzyme [18-20] which replaces the encoded guanine at the 
wobble position with the queuine precursor 7-aminomethyl-7-
deazaguanine (preQi; Fig. 1), although guanine and the 
queuine precursor 7-cyano-7-deazaguanine (preQo; Fig. 1), 
but not queuine, are also accepted as substrates in vitro 
[21,22]. Additionally, an anticodon stem-loop having a 
U33G34U35 sequence has been shown to be a minimal sub-
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strate for Escherichia coli TGT [23-25]. We have recently 
solved the structure of Zymomonas mobilis TGT, alone and 
in complex with preQi [20,26,27]. The enzyme adopts a non-
canonical (ß/oc)8-barrel fold with the preQi-binding pocket 
located at the C-terminal face of the barrel. By band-shift 
assays and mutagenesis we have shown that the catalytic 
mechanism of prokaryotic TGT proceeds via the formation 
of a TGT/tRNA covalent intermediate, with Asp102 being the 
active site nucleophile of Z. mobilis TGT [28]. 
In eukaryotes, queuine is a nutrient and the replacement of 
the wobble guanine with queuine is carried out in a single 
enzymatic step, even though guanine, preQo and preQi are 
also substrates in vitro [29,30]. The U33G34U35 sequence is 
also specifically recognized by the eukaryotic TGT [31]. How-
ever, contradictory data concerning the size and the oligomer-
ic state of eukaryotic TGTs have been reported [29,30,32]. 
Recently, an archaebacterial TGT was isolated from Halo-
ferax volcanii [33]. This enzyme is a 78 kDa protein which has 
been shown, through partial sequencing, to be sequence-re-
lated to the prokaryotic enzyme. However, the archaebacterial 
protein replaces the encoded guanine at position 15 in the 
dihydrouridine loop with preQo, guanine being also a sub-
strate in vitro but not preQi or queuine [33]. 
2. Materials and methods 
The Shigella flexneri (SWISS-PROT accession code Q54177), Hae-
mophilus influenza (SWISS-PROT accession code P44594), Helico-
bacter pylori (EMBL accession code Y12061), Synechocystis sp. 
(SWISS-PROT accession code Q55983), Thermotoga maritima 
(TIGR), Caenorhabditis elegans (EMBL accession code Z73899), 
mouse (EST), human (EST), Methanoccocus jannaschii (EMBL acces-
sion code U67495), Archaeoglobus fulgidus (TIGR) and Methanobac-
terium thermoautotrophicum (GTC) sequences were retrieved from the 
EMBL (European Molecular Biology Laboratory), SWISS-PROT, 
EST (Expressed Sequence Tags), TIGR (The Institute for Genomic 
Research, personal communication) and GTC (Genome Therapeutics 
Corporation, personal communication) databases. The Zymomonas 
mobilis (SWISS-PROT accession code P28720) and Escherichia coli 
(SWISS-PROT accession code P19675) sequences were used as start-
ing search sequences within BLASTN [34]. When necessary, this 
search was repeated with full-length eukaryotic and archaebacterial 
sequences for full complementarity. The alignment of the sequences 
was done with CLUSTALW [35]. 
The mouse and human sequences were partially reconstructed from 
sufficiently long cDNA fragments stored in the EST databases. It 
should be noted that other eukaryotic proteins within the databases 
have been annotated as tRNA-guanine transglycosylases (SWISS-
PROT accession codes P54578, P40826 and Q17361). These proteins 
are totally unrelated in sequence to the prokaryotic TGTs and the 
presence of homologs in the genome of Saccharomyces cerevisiae (ac-
cession name YFROlOw) and S. pombe (EMBL accession code 
Z81317), organisms devoid of any 7-deazaguanine derivatives, 
strongly suggests that these proteins are not the eukaryotic TGTs. 
Other partial sequences from Vibrio cholerae, Deinococcus 
radiodurans, Plasmodium falciparum, Toxoplasma gondii, rice and Dro-
0014-5793/97/S17.00 © 1997 Federation of European Biochemical Societies. All rights reserved. 
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sophila melanogaster were also retrieved from these databases. As 
these sequences are too short they are not shown but they support 
the conclusions drawn from the full-length sequences. 
The M. jannaschii and M. thermoautotrophicum sequences have 
been obtained assuming a frameshift during sequencing which trun-
cated the proteins at their N- and C-terminus, respectively. Use of 
different frames restored parts strongly homologous to the other ar-
chaebacterial sequences. Due to possible other sequencing errors, the 
exact N- and C-termini of the latter protein could not be precisely 
defined and a few extra residues may be present at both locations. The 
T. maritima and A. fulgidus sequences have been partially recon-
structed from sufficiently long prokaryotic and archaebacterial homol-
ogous sequences found in their newly released genomes. Due to the 
unavailability of their DNA sequences, it is still impossible to confirm 
whether these sequences are contiguous on the genome. 
The homology modeling of the three-dimensional structures of the 
C. elegans and the N-terminal part of the M. jannaschii proteins was 
carried out within TURBO-FRODO [36] using the X-ray structure of 
the Z. mobilis TGT/preQi complex [27] as template. The active site 
vicinity of both proteins was refined stereochemically using TURBO-
FRODO and X-PLOR [37]. 
3. Results 
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Fig. 1. Chemical structures of guanine and the different 7-deazagua-
nine derivatives. 
A search of sequence databases for protein sequences ho-
mologous to the prokaryotic TGTs yields, besides the various 
prokaryotic sequences, significant hits for eukaryotic and 
archaebacterial proteins (Fig. 2). Whereas the eukaryotic pro-
teins have about the same length as the prokaryotic TGTs and 
are ~ 4 0 % identical to them in sequence (Table 1 ; Fig. 2), the 
archaebacterial proteins are also clearly homologous to the 
prokaryotic TGTs but have about 300 additional residues at 
their C-terminus (Fig. 2). This C-terminal part is not as con-
served as the N-terminal one and shows no homology to any 
other protein sequence. However, the zinc ligands and the 
nucleophilic aspartate are conserved in all the enzymes 
(Fig. 2). 
The high homology between these proteins and knowledge 
of the three-dimensional structure of Z. mobilis TGT allowed 
the modeling of the С elegans and the N-terminal part of the 
M. jannaschii proteins, in particular their active sites. Assum-
ing that these proteins represent the eukaryotic and archae-
bacterial TGTs, it should be possible to explain their different 
substrate specificities on the basis of amino acid substitutions 
observed in the active site vicinity. For this purpose, the struc-
ture of the Z. mobilis TGT/preQi complex was used as a 
template for modeling of the complexes between the proteins 
and the various modified bases. Especially, the position of the 
7-deazaguanine moiety was kept as observed experimentally. 
In the Z mobilis TGT/preQi structure, the base is found 
sandwiched between the side chains of Met260 on one side, 
and Tyr106 and Cys158 on the other side. The 7-deazaguanine 
moiety is specifically recognized through hydrogen bonding 
between the carboxylate of Asp156 and the 1-NH and 2-
NH2 groups of preQi, and between the amide nitrogen of 
Gly230 and the oxygen Об of preQi (Fig. ЗА). It should be 
noted that this recognition pattern is also a guanine recogni-
tion motif present in many proteins binding a guanine moiety 
[38]. The additional amino group of preQi contributes to 
recognition by forming a hydrogen bond with the carboxyl 
oxygen of Leu231 (Fig. ЗА). A preQo molecule could also be 
recognized in this site since the partial negative charge of the 
cyano nitrogen would be in hydrogen bonding distance to the 
amide nitrogen of Leu231 due to the linearity of the CCN 
group (data not shown). This recognition requires a slight 
tilting of the base, but preQi is also able to adopt such an 
orientation when bound to TGT [27]. On the other hand, a 
queuine molecule does not fit into this pocket because of steric 
interference with Val233 which forms the ceiling of the pocket 
(Fig. ЗА). These results are in agreement with the substrate 
specificity of E. coli TGT [21,22]. 
Very few changes are observed in the binding pocket of the 
eukaryotic enzyme. Cys158 is replaced by a valine, a mutation 
which should not prevent the hydrophobic interaction with 
the 7-aminomethyl moiety of the base. However, the smaller 
volume of a valine at this position combined with the replace-
ment of Val233 by a glycine enlarges the binding pocket and 
allows a queuine molecule to bind (Fig. 3B). Actually, the 
interactions between the protein and the preQi moiety are 
conserved, but an additional hydrophobic interaction between 
the cyclopentenediol moiety of queuine and Val158 is ob-
served. As for the two hydroxyls, they are in hydrogen bond-
ing distance to several carbonyl oxygens of the protein main 
chain. Since the preQi binding specificity is not changed, gua-
nine, preQo and preQi should also bind in this pocket, as it 
has been previously observed [29,30]. 
In the archaebacterial case, more sequence changes are ob-
served. Here, Met260 is replaced by a phenylalanine, a muta-
tion which should, however, not perturb the stacking of the 
base (Fig. 3C). More important are the other mutations lo-
cated within or in the vicinity of the binding pocket. First, 
both Cys158 and Tyr161 are mutated into prolines. Although 
Fig. 2. Alignment of the Z. mobilis (Z.mobi), E. coli (E.coli), S. flexneri (S.flex), H. influenza (H.infl), H. pylori (H.pylo), Synechococcus sp. 
(S.sp.), T. maritima (T.mari), C. elegans (C.eleg), mouse, human, M. jannaschii (M.jann), A. fulgidus (A.fulg) and M. thermoautotrophicum 
(M.ther) TGT sequences. The human and mouse sequences are not complete and gaps may represent missing data. Residues described in the 
text have been labeled with Z mobilis numbers. Asp102, marked with an asterisk, is the active site nucleophile of Z mobilis TGT. The four 
zinc ligands are marked 'Zinc'. The amino acid marked 'Additional Proline' is the proline residue found exclusively in the archaebacterial se-
quences. The additional C-terminal residues of these latter sequences are not shown (marked as '...'). 
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Fig. 3. Recognition of the cognate 7-deazaguanine derivatives by the various TGTs. For clarity the Z mobilis numbering has been kept in all 
proteins. A: Observed recognition of preQi by Z. mobilis TGT. B: Modeled recognition of queuine by С elegans TGT. C: Modeled recogni-
tion of preQo by M. jannaschii TGT. The residue marked Proline is the additional proline found exclusively in the archaebacterial sequences. 
the former mutation does not change the hydrophobic char-
acter of the binding pocket at this location, the latter creates a 
stronger steric hindrance. Indeed, as the side chain of Tyr161 
was pointing outwards, the proline is bulging out above the 
binding pocket (Fig. 3C). Facing this proline is a leucine 
which replaces the prokaryotic Val233. This bulkier residue 
cannot be accommodated where the valine previously was 
because of the bulging proline opposite to it. Consequently, 
the loop formed by residues Val231 to Glu235 is pushed slightly 
downwards and towards the center of the binding pocket (Fig. 
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Table 1 
Sequence identities between prokaryotic, eukaryotic and archaebacterial TGTs 
Z.mobi 
E.coli 
S.flex 
H.infl 
H.pylo 
S.sp. 
T.mari 
C.eleg 
Mouse 
Human 
M.jann 
A.fulg 
E.coli 
54.9" 
S.flex 
55.2 
99.2 
H.infl 
55.2 
81.6 
81.6 
H.pulo 
43.1 
45.0 
45.6 
43.9 
S.sp. 
42.5 
42.0 
42.3 
40.4 
38.0 
T.mari 
46.7 
48.1 
48.9 
47.0 
41.0 
45.1 
C.eleg 
38.4 
40.0 
40.3 
40.4 
37.2 
41.2 
41.6 
Mouse 
39.1 
38.3 
38.6 
39.7 
34.6 
39.1 
36.9 
50.3 
Human 
49.0 
46.9 
47.3 
49.4 
46.9 
50.6 
49.0 
54.8 
63.1 
M.jann 
22.9b 
25.9 
26.1 
24.6 
22.6 
23.0 
25.8 
19.0 
20.4 
19.9 
A.fulg 
21.0 
22.4 
22.4 
19.9 
20.2 
20.9 
22.3 
17.4 
19.6 
19.9 
51.8 
M.ther 
22.6 
24.5 
24.5 
22.3 
22.9 
22.5 
25.0 
18.1 
19.0 
21.2 
52.6 
48.5 
"All values are given as percentages. 
bFor the archaebacterial proteins, only the N-terminal part has been considered for calculations. 
3C). Moreover, an additional proline - not present in the 
prokaryotic or eukaryotic proteins - is inserted immediately 
before the leucine (Fig. 2). Its role might be to rigidify and/or 
help to adjust the conformational change of the loop. Alto-
gether, these modifications prevent the recognition of preQi -
and of course of archaeosine and queuine - by restricting the 
volume of the pocket in the region where its additional amino 
group binds. However, there is still enough space for binding 
a preQo - or a guanine - molecule, in agreement with the 
observed substrate specificity of the archaebacterial TGT [33]. 
4. Discussion 
Altogether, the results presented here strongly favor the 
hypothesis that the eukaryotic and archaebacterial proteins 
described are the tRNA-guanine transglycosylases of these 
two kingdoms and that all TGTs adopt a common fold. These 
findings are unexpected. First, no trace of an ancient queuine 
biosynthesis pathway has been found in eukaryotes, and the 
eukaryotic TGT recognizes directly queuine, a molecule much 
more bulky than preQi. Second, in archaebacteria the incor-
poration of preQo is done at a totally different location of the 
tRNA and requires a completely different mode of tRNA 
recognition. 
The prokaryotic and eukaryotic TGTs recognize the anti-
codon stem-loop of their cognate tRNAs, especially the spe-
cific U33G34U35 sequence [23-25,31]. The high homology be-
tween these proteins explain why they display the same 
specificity towards tRNA. Especially, the two arginines 286 
and 289 which have been postulated to play a major role in 
the binding of the anticodon stem-loop phosphate backbone 
and other residues (Asn70, His73, Thr71 and Asp267) which 
have been implicated in the specific UGU sequence recogni-
tion [27] are, with the exception of Asp267, totally conserved in 
the eukaryotic proteins (Fig. 2). 
On the other hand, archaebacterial TGTs recognize the D-
loop of archaebacterial tRNAs having a guanine at position 
15 [16]. The additional 300 residues and/or the larger number 
of amino acid substitutions in the archaebacterial enzymes 
could be responsible for the difference in tRNA recognition. 
Furthermore, arginines 286 and 289, His73, Asn70, Thr71 and 
Asp267 are not highly conserved in these proteins (Fig. 2). 
We have shown that prokaryotic TGTs catalyze their reac-
tion via the formation of a protein/tRNA covalent intermedi-
ate, Asp102 being the active site nucleophile of Z. mobilis 
TGT, and have suggested that the wobble guanine is recog-
nized within the preQi-binding pocket [27,28]. The total con-
servation of the nucleophile aspartate and of Gin107 - as-
sumed to recognize the 0 2 ' hydroxyl of the wobble guanine 
- together with the fact that all the enzymes are able to rec-
ognize guanine in their 7-deazaguanine-binding pockets are in 
agreement with a base exchange mechanism for the synthesis 
of the various 7-deazaguanine-modified tRNAs based upon a 
common protein fold and a similar catalytic mechanism, in-
cluding mammals. 
Finally, the case of T. maritima, an organism which has 
diverged quite early from the other prokaryotes, raises the 
question of the evolutionary relationship between the different 
TGTs. Indeed, T. maritima TGT, even though it is highly 
homologous to the other prokaryotic TGTs (Table 1 and 
Figs. 2 and 3), displays a few features characteristic for the 
archaebacterial TGTs, especially a proline is found at position 
161 and an isoleucine at position 233. On the other hand, it 
does not have an additional proline within the loop formed by 
residues 231-235. It therefore remains to be determined 
whether this protein uses as substrate preQi or preQo, this 
latter precursor being also found in prokaryotes [39]. If these 
hypotheses are relevant, they could indicate two possible evo-
lutionary pathways. According to the first, the archaebacterial 
proteins could have evolved by protein fusion from an ances-
tor using preQo, and possibly close to the T. maritima TGT, 
in order to synthesize archaeosine in their tRNAs and there-
fore, through its structural role, to adapt to their challenging 
environments. Alternatively, the prokaryotic and eukaryotic 
proteins could have evolved from a common ancestor in-
volved in archaeosine synthesis and used it to synthesize 
queuine in their tRNAs to cope with their more complicated 
translational events. In both cases, the eukaryotes would have 
discarded most of their queuine biosynthesis proteins to use 
queuine as a mere nutrient. 
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